Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation

Physiological Research

Volumn 57, Issue 6, 2008, Pages 1-18

  Kuncová, Jitka ^a   Faitová, Šárka ^a   Capouch, Jan ^a   Štengl, Milan ^a   Slavíková, Jana ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atropine; Heart atria; Rat; Vagus nerve stimulation; Vasoactive intestinal polypeptide

Indexed keywords

EID: 58849166967     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. ANDERSON FL, KRALIOS AC, CLUFF N, HANSON GR: Vagal-induced tachycardia: release of vasoactive intestinal peptide and peptide HI. Am J Physiol 267: H2019-H2024, 1994.
2. ANDERSON FL, KRALIOS AC, REID B, HANSON GR: Release of vasoactive intestinal peptide and neuropeptide Y from canine heart. Am J Physiol 265: H959-H965, 1993.
3. ANDERSON FL, WYNN JR, KIMBALL J, HANSON GR, HAMMOND E, HERSHBERGER R, KRALIOS AC: Vasoactive intestinal peptide in canine hearts: effect of total cardiac denervation. Am J Physiol 262: H598-602, 1992.
4. ARMOUR JA: Myocardial ischaemia and the cardiac nervous system. Cardiovasc Res 41: 41-54, 1999.
5. ASZTELY A, EKMAN R, TOBIN G, EKSTROM J: Depletion of vasoactive intestinal peptide and substance P in parotid glands of atropinized rats during reflex secretion. Exp Physiol 81: 297-303, 1996.
6. BALAS N, ARAD M, RABINOWITZ B, SHAINBERG A: Modulation of cardiac A1-adenosine receptors in rats following treatment with agents affecting heart rate. Mol Cell Biochem 231: 107-116, 2002.
7. BARRETT J, MCDOUGALL JJ, MORRISON JD: Enhancement by atropine of the pancreatic exocrine secretions evoked by vagal stimulation in the pithed rat. J Physiol 469: 443-457, 1993.
8. BRUM JM, BOVE AA, SUFAN Q, REILLY W, GO VL: Action and localization of vasoactive intestinal peptide in the coronary circulation: evidence for nonadrenergic, noncholinergic coronary regulation. J Am Coll Cardiol 7: 406-413, 1986.
9. CAWLEY TA JR, SHICKLEY TJ, RUGGIERI MR, LUTHIN GR: Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors. J Pharmacol Exp Ther 267: 134-139, 1993.
10. DAS DK, KALFIN R, MAULIK N, ENGELMAN RM: Coordinated Role of Vasoactive Intestinal Peptide and Nitric Oxide in Cardioprotection. Ann NY Acad Sci 865: 297-308, 1998.
11. DELLA NG, PAPKA RE, FURNESS JB, COSTA M: Vasoactive intestinal peptide-like immunoreactivity in nerves associated with the cardiovascular system of guinea-pigs. Neuroscience 9: 605-619, 1983.
12. FAHRENKRUG J: Vasoactive intestinal polypeptide: Measurement, distribution and putative neurotransmitter function. Digestion 19: 149-169, 1979.
13. FELICIANO L, HENNING RJ: Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow. Cardivasc Res 40: 45-55, 1998.
14. FORSGREN S: Vasoactive intestinal polypeptide-like immunoreactivity in the bovine heart: high degree of coexistence with neuropeptide Y-like immunoreactivity. Cell Tissue Res 256: 125-135, 1989.
15. GULBENKIAN S, SAETRUM-OPGAARD O, EKMAN R, COSTA AN, WHARTON J, POLAK JM, QUEIROZ MJ, EDVINSSON L: Peptidergic innervation of human epicardial coronary arteries. Circ Res 73: 579-588, 1993.
16. HALFACREE ZJ, READ PA, EDWARDS AV: Pancreatic exocrine responses to parasympathetic stimulation in anaesthetized pigs. Auton Neurosci 87: 217-224, 2001.
17. HAVEL PJ, DUNNING BE, VERCHERE CB, BASKIN DG, O'DORISIO T, TABORSKY GJ: Evidence that vasoactive intestinal polypeptide is a parasympathetic neurotransmitter in the endocrine pancreas in dogs. Regul Pept 71: 163-170, 1997.
18. HEDLUND B, ABENS J, BARTFAI T: Vasoactive intestinal polypeptide and muscarinic receptors: supersensitivity induced by long-term atropine treatment. Science 220: 519-521, 1983.
19. HENNING RJ, FELICIANO L, COERS CM: Vagal nerve stimulation increases right ventricular contraction and relaxation and heart rate. Cardiovasc Res 32: 846-853, 1996.
20. HENNING RJ, SAWMILLER DR: Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc Res 49: 27-37, 2001.
21. HEYM C, REINECKE M, WEIHE E, FORSSMANN WG: Dopamine-beta-hydroxylase-, neurotensin-, substance P-, vasoactive intestinal polypeptide- and enkephalin-immunohistochemistry of paravertebral and prevertebral ganglia in the cat. Cell Tissue Res 235: 411-418, 1984.
22. HILL MR, WALLICK DW, MARTIN PJ, LEVY MN: Effects of repetitive vagal stimulation on heart rate and on cardiac vasoactive intestinal polypeptide efflux. Am J Physiol 268: H1939-H1946, 1995.
23. HOGAN K, MARKOS F: An Investigation into the Presence of a Vagal Tachycardia and the Effect of Vasoactive Intestinal Polypeptide on the Rat Heart Rate in vitro. Pharmacology 76: 101-104, 2006a.
24. HOGAN K, MARKOS F: Vasoactive intestinal polypeptide receptor antagonism enhances the vagally induced increase in cardiac interval of the rat atrium in vitro. Exp Physiol 91: 641-646, 2006b.
25. HOKFELT T: Neuropeptides in perspective: the last ten years. Neuron 7: 867-879, 1991.
26. HORACKOVA M, ARMOUR JA, BYCZKO Z: Distribution of intrinsic cardiac neurons in wholemount guinea pig atria identified by multiple neurochemical coding. A confocal microscope study. Cell Tissue Res 297: 409-421, 1999.
27. HORACKOVA M, SLAVIKOVA J, BYCZKO Z: Postnatal development of the rat intrinsic cardiac nervous system: a confocal laser scanning microscopy study in whole-mount atria. Tissue Cell 32: 377-388, 2000.
28. KALFIN R, MAULIK N, ENGELMAN RM, CORDIS GA, MILENOV K, KASAKOV L, DAS DK: Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium. J Pharmacol Exp Ther 288: 952-958, 1994.
29. KRISTENSEN B, GEORG B, FAHRENKRUG J: Cholinergic regulation of VIP gene expression in human neuroblastoma cells. Brain Res 775: 99-106, 1997.
30. KUNCOVA J, SLAVIKOVA J: Distribution of vasoactive intestinal polypeptide in the rat heart: effect of guanethidine and capsaicin. Ann Anat 185: 153-161, 2003.
31. LAPCHAK PA, BEAUDET A: Cholinergic regulation of vasoactive intestinal peptide content and release in rat frontal cortex and hippocampus. J Neurochem 55: 1340-1345, 1990.
32. LOFFELHOLZ K, PAPPANO AJ: The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 37: 1-24, 1985.
33. LUNDBERG JM, ANGGARD A, FAHRENKRUG J: Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum. Acta Physiol Scand 113: 329-363, 1981.
34. LUNDBERG JM: Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurones of cat exocrine glands. Morphological, biochemical and functional studies. Acta Physiol Scand (Suppl) 496: 1-57, 1981.
35. LUNDBERG JM: Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48: 113-178, 1996.
36. MABE AM, HOARD JL, DUFFOURC MM, HOOVER DB: Localization of cholinergic innervation and neurturin receptors in adult mouse heart and expression of the neurturin gene. Cell Tissue Res 326: 57-67, 2006.
37. MYSLIVECEK J, TROJAN S, TUCEK S: Biphasic changes in the density of muscarinic and betaadrenergic receptors in cardiac atria of rats treated with diisopropylfluorophosphate. Life Sci 58: 2423-2430, 1996.
38. PARSONS RL, LOCKNAR SA, YOUNG BA, HOARD JL, HOOVER DB: Presence and colocalization of vasoactive intestinal polypeptide with neuronal nitric oxide synthase in cells and nerve fibers within guinea pig intrinsic cardiac ganglia and cardiac tissue. Cell Tissue Res 323: 197-209, 2006.
39. PETIT JM, DENOROY L, JOUVET M: Effects of chronic atropine administration on regional vasoactive intestinal polypeptide concentrations in rat brain. Eur J Pharmacol 212: 79-85, 1992.
40. SAID SI, MUTT V: Polypeptide with broad biological activity: isolation from small intestine. Science 169: 1217-1218, 1970.
41. ROOSSIEN A, BRUNSTING JR, NIJMEIJER A, ZAAGSMA J, ZIJLSTRA WG: Effects of vasoactive intestinal polypeptide on heart rate in relation to vagal cardioacceleration in conscious dogs. Cardiovasc Res 33: 392-399, 1997.
42. SAID SI: Vasoactive intestinal polypeptide (VIP): current status. Peptides 5: 143-150, 1984.
43. SANCHEZ-VICENTE C, RODRIGUEZ-NODAL F, MINGUELA A, GARCIA LJ, SAN ROMAN JI, CALVO JJ, LOPEZ MA: Cholinergic pathways are involved in secretin and VIP release and the exocrine pancreatic response after intraduodenally perfused acetic and lactic acids in the rat. Pancreas 10: 93-99, 1995.
44. SAWMILLER DS, HENNING RJ, CUEVAS J, DEHAVEN WI, VESELY DL: Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart. Neuropeptides 38: 289-297, 2004.
45. SCHMIDT P, RASMUSSEN TN, HOLST JJ: Release of immunoreactive somatostatin, vasoactive intestinal polypeptide (VIP), and galanin during propulsive complexes in isolated pig ileum. Peptides 14: 215-220, 1993.
46. SHVILKIN A, DANILO P JR, CHEVALIER P, CHANG F, COHEN IS, ROSEN MR: Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart. Cardiovasc Res 28: 1769-1773, 1994.
47. SLAVIKOVA J: Distribution of peptide-containing neurons in the developing rat right atrium, studied using immunofluorescence and confocal laser scanning. Neurochem Res 22: 1013-1021, 1997.
48. STEELE PA, GIBBINS IL, MORRIS JL: Projections of intrinsic cardiac neurons to different targets in the guinea-pig heart. J Auton Nerv Syst 56: 191-200, 1996.
49. TOBIN G, EKSTROM J, BLOOM SR, EDWARDS VA: Atropine-resistant submandibular responses to stimulation of the parasympathetic innervation in the anaesthetized ferret. J Physiol 437: 327-339, 1991.
50. TOBIN G, EKSTROM J, EKMAN R, HAKANSON R: Influence of atropine on the depletion of vasoactive intestinal peptide, substance P and calcitonin gene-related peptide from rat parotid gland in response to parasympathetic nerve stimulation. Acta Physiol Scand 150: 463-465, 1994.
51. UNO Y, MATSUMURA K, SCHEFFEL U, WILSON AA, DANNALS RF, WAGNER HN JR: Effects of atropine treatment on in vitro and in vivo binding of 4-[125I]-dexetimide to central and myocardial muscarinic receptors. Eur J Nucl Med 18: 447-452, 1991.